5 ms·
I hope I can be forgiven to not read every single study the article references... But isn't there tremendous Economic incentive to prove asprin is dangerous? B
by throwayEngineer 7y ago
I hope I can be forgiven to not read every single study the article references... But isn't there tremendous Economic incentive to prove asprin is dangerous?
But there are lots of people who's job depends on high asprin sales.
I am concerned this phenomenon creeps over into these studies.
- WaltPurvis 7y agoI'm not 100% sure what you're saying, but aspirin is probably the cheapest drug in the world. Nobody is making huge profits from aspirin.
- throwayEngineer 7y agoSource? It's one of the most common medications. At scale I imagine even small margins create profit.
- osrec 7y agoI doubt it. It's a generic that anyone can manufacture and that invariably will squeeze profit margins to almost nothing. In the UK, many supermarkets sell their own brand aspirin and paracetamol for pennies, as loss leaders.
- adventured 7y agoGeneric Equate brand Asprin is $3.64 for a 500 count bottle at Walmart. 3/4 of a penny per Asprin. Nobody is printing consequential profit on that. And that's the cost in what is by far the world's most expensive healthcare environment. The other comment is correct, the competitive market for generic Asprin generally makes it a very low profit product category. The only way to make a bit of money in Asprin, is eg what Bayer does, sell things like orange flavored chewables in their low-dose subset (which is then immediately undercut by generics anyway; Bayer's 300 count version is $10 at Walgreens, the generic version is $6; two to three pennies per).
- BurningFrog 7y agoSurely the incentive of this supposedly big asprin industry would be to prove asprin is safe?
- amelius 7y agoI assume the commenter was talking about other drug companies, e.g. those making drugs for heart disease.